The updated National Coverage Determination (NCD) for transcatheter aortic valve replacement (TAVR) may change certain federal registry requirements.
As our partners in improving quality of care and outcomes for structural heart patients across Michigan, we hope you will agree that it does not diminish the value of participating in the Michigan Structural Heart Consortium (MISHC).
Continuing with MISHC offers a sustained focus on patient outcomes and meaningful return on investment by combining statewide collaboration, financial and operational support, and actionable data.
Continued participation matters. Read our Q&A and Values and Return on Investment for more information.
Why MISHC?
MISHC's Value
The value of MISHC is not simply collecting data – it is turning reliable data into better decisions, more efficient improvement, and better outcomes for structural heart patients.
Q&A
Key Takeaway: The updated federal policy may change certain registry requirements, but it does not change MISHC’s commitment to the TVT Registry, the multidisciplinary Heart Team, patient-centered outcomes such as the KCCQ, registry-based quality collaboration, national benchmarking, or continuous quality improvement.